Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines

Imlifidase recently received early access authorization for highly sensitized adult kidney transplant candidates with a positive crossmatch against an ABO-compatible deceased donor. These French consensus guidelines have been generated by an expert working group, in order to homogenize patient selec...

Descripción completa

Detalles Bibliográficos
Autores principales: Couzi, Lionel, Malvezzi, Paolo, Amrouche, Lucile, Anglicheau, Dany, Blancho, Gilles, Caillard, Sophie, Freist, Marine, Guidicelli, Gwenda Line, Kamar, Nassim, Lefaucheur, Carmen, Mariat, Christophe, Koenig, Alice, Noble, Johan, Thaunat, Olivier, Thierry, Antoine, Taupin, Jean-Luc, Bertrand, Dominique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336835/
https://www.ncbi.nlm.nih.gov/pubmed/37448448
http://dx.doi.org/10.3389/ti.2023.11244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336835/
https://www.ncbi.nlm.nih.gov/pubmed/37448448
http://dx.doi.org/10.3389/ti.2023.11244

Ejemplares similares